News Hub

Jun 1, 2026

Jordan Park

Press Releases

PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets

PMGC Holdings Inc. has signed a non-binding Letter of Intent to acquire a 76% controlling stake in a U.S.-based precision machining company specializing in high-tolerance CNC machining for aerospace, space, defense, semiconductor, and other industrial sectors. The target company is certified and compliant with industry standards, has recurring reve…

ELAB

Jun 1, 2026

Marcus Reed

Insider Trading

Matador Resources Executive's Purchase Signals Internal Confidence Amid Strategic Expansion

The recent purchase of Matador Resources Co (MTDR) stock by its Executive Vice President and Chief Operating Officer, Glenn W. Stetson, suggests internal confidence in the company's direction. This transaction occurs against a backdrop of mixed financial results for Q1 2026, where earnings per share surpassed expectations, yet total revenue fell be…

Jun 1, 2026

Caleb Monroe

Stock Markets

JetBlue lifts Q2 fuel cost outlook, cites operational resilience and route gains

JetBlue raised its second-quarter jet fuel cost estimate to $4.26-$4.36 per gallon, up from a prior range of $4.13-$4.28, amid industry-wide pressure from disruptions tied to the closure of the Strait of Hormuz. The carrier said it expects to recapture 40% or more of the higher fuel expense in the quarter due to steady operations, and it pushed its…

Jun 1, 2026

Derek Hwang

Press Releases

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Immuneering Corporation announced updated data from its Phase 2a trial showing a median overall survival of 17.3 months in first-line metastatic pancreatic cancer patients treated with atebimetinib plus modified gemcitabine/nab-paclitaxel chemotherapy, nearly double the survival seen in historical controls. The treatment demonstrated a favorable sa…

IMRX

Jun 1, 2026

Avery Klein

Press Releases

XCharge Appoints Albina Iljasov as Co-Chief Executive Officer

XCHG Limited, a Nasdaq-listed integrated EV charging and energy solutions company, appointed Albina Iljasov as Co-Chief Executive Officer effective June 1, 2026. Iljasov will oversee European operations and spearhead information security and cybersecurity efforts, complementing existing Co-CEO Yifei Hou. The move signals XCharge's commitment to glo…

XCH

Jun 1, 2026

Leila Farooq

Press Releases

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Iovance Biotherapeutics announced FDA clearance of their investigational new drug (IND) application for IOV-5001, a next-generation interleukin-12 (IL-12) tethered tumor infiltrating lymphocyte (TIL) therapy. The Phase 1/2 trial aims to treat multiple advanced solid tumors including colorectal and breast cancers, with enrollment expected in the sec…

IOVA

Jun 1, 2026

Derek Hwang

Press Releases

SL Green Announces the Sale of 10 East 53rd Street

SL Green Realty Corp., Manhattan's largest office landlord, announced the sale of 10 East 53rd Street to Meadow Partners for $312.2 million. The sale, expected to close in Q3 2026, will generate approximately $100 million in net cash proceeds to reduce corporate debt. This transaction advances SL Green's $2.5 billion strategic disposition plan and …

SLG

Jun 1, 2026

Jordan Park

Press Releases

Anterix Sets Fourth Quarter Fiscal 2026 Earnings Conference Call for Thursday, June 11, at 9:00 a.m. ET

Anterix Inc., a leading provider of private wireless broadband spectrum solutions for critical infrastructure, announced its fourth quarter fiscal 2026 earnings conference call will take place on June 11, 2026. The company will discuss its quarterly results following a press release after market close on June 10. Anterix continues to focus on deliv…

ATEX

Jun 1, 2026

Hana Yamamoto

Press Releases

Cognition Therapeutics Participating in Upcoming Investor Conferences

Cognition Therapeutics, a clinical-stage biopharmaceutical company focused on neurodegenerative diseases, announced CEO Lisa Ricciardi will present at two upcoming investor conferences, sharing updates on the company's development plans for its lead drug candidate zervimesine (CT1812), targeting dementia with Lewy bodies (DLB) psychosis. The compan…

CGTX

Jun 1, 2026

Jordan Park

Press Releases

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

Cytokinetics announced the commercial launch of MYQORZO® (aficamten) in Germany, marking its first European availability for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). This follows FDA approval and market introduction in the U.S. and China. The European Commission approved MYQORZO based on positive Phase 3 clinical trial results de…

CYTK

Jun 1, 2026

Jordan Park

Press Releases

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx Corp., a healthcare technology company specializing in AI-driven marketing solutions for life sciences, announced that its management will participate in prominent investor conferences including the Stifel 2026 Boston Cross Sector Conference and the 46th Annual William Blair Growth Stock Conference. The participation aims to showcase the…

OPRX

Jun 1, 2026

Marcus Reed

Press Releases

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

TG Therapeutics announced publication of post-hoc pooled analyses from the Phase 3 ULTIMATE I & II trials demonstrating that BRIUMVI (ublituximab-xiiy) provides significant clinical and MRI improvements versus teriflunomide in treatment-naïve adult patients with relapsing multiple sclerosis (RMS). The data supports early use of this high-efficacy t…

TGTX

Jun 1, 2026

Nina Shah

Press Releases

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Intellia Therapeutics announced it will present additional data from its global Phase 3 HAELO trial of lonvo-z, a one-time CRISPR-based gene editing therapy for hereditary angioedema (HAE), at the EAACI 2026 Congress. This late-breaking oral presentation highlights the potential of lonvo-z to become the first permanent treatment to prevent HAE atta…

NTLA

Jun 1, 2026

Ajmal Hussain

Press Releases

Athene Announces Key Leadership Appointment

Athene, a leading retirement solutions company and subsidiary of Apollo Global Management, appointed Matthew Michelini as President of Athene Holding Ltd., effective July 1, 2026. Michelini brings extensive experience from Apollo, including leadership in Asia-Pacific, and will focus on advancing growth initiatives and reinventing guaranteed lifetim…

APO

Jun 1, 2026

Priya Menon

Press Releases

HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs

HCI Group successfully completed its 2026-2027 catastrophe reinsurance programs, securing $4.1 billion in excess of loss coverage, a 16% increase year-over-year, while reducing net reinsurance premiums by 10%. The company enhanced its risk transfer strategy with meaningful structural improvements and expanded participation of its Cayman Islands rei…

HCI

Jun 1, 2026

Avery Klein

Press Releases

Nayax Launches AI-Powered Product Discovery for Retailers

Nayax Ltd., a global payments and commerce enablement platform, launched a new AI-powered product discovery and personalization feature integrated into its platform. This solution helps retailers utilize real-time shopper data across multiple channels to provide personalized recommendations, thereby increasing customer engagement and sales. The pro…

NYAX

Jun 1, 2026

Sofia Navarro

Press Releases

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, announced that Interim CEO Eric So will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 4, 2026. The company is advancing proprietary drugs HLP003 and HLP004 for major depressive…

HELP

Jun 1, 2026

Marcus Reed

Press Releases

BriaCell Presents Positive Clinical Data at ASCO 2026

BriaCell Therapeutics Corp. announced positive clinical data from Phase 2 and ongoing Phase 3 studies of its Bria-IMT immunotherapy for heavily pre-treated metastatic breast cancer patients at the 2026 ASCO Annual Meeting. Data demonstrated promising survival rates, good quality of life, and potential predictive biomarkers, supporting continued dev…

BCTX

Jun 1, 2026

Caleb Monroe

Stock Markets

ERock files for U.S. IPO aiming to raise $641.9M and pursue up to $5B valuation

Houston-based ERock has filed to raise up to $641.9 million in a U.S. initial public offering, proposing to sell 27.9 million shares at $20 to $23 each and target a valuation of as much as $5 billion. The natural gas generator maker, which serves data centers, utilities and commercial and industrial customers across nine states, reported roughly $1…

Jun 1, 2026

Maya Rios

Stock Markets

AMD Shares Slip After U.S. Tightens Export Guidance on High-End AI Chips

Advanced Micro Devices shares tumbled in pre-market trading after the U.S. Commerce Department’s Bureau of Industry and Security issued guidance that closes a previously exploited channel for shipping MI350x AI accelerators to Chinese-controlled subsidiaries outside mainland China. The move increases compliance burdens and clouds near-term demand f…

Jun 1, 2026

Caleb Monroe

World

Senator Jose "Jinggoy" Estrada Surrenders After Anti-Graft Court Orders Arrest

A Philippine senator surrendered to police after an anti-graft court issued an arrest order charging him with plunder for allegedly receiving 573 million pesos in illicit payments linked to a corruption scandal over defective flood-control facilities. He denied wrongdoing, called the case politically motivated and said he would not seek refuge in t…

Jun 1, 2026

Hana Yamamoto

Stock Markets

Qualcomm Shares Plunge After Nvidia Unveils RTX Spark Superchip at Computex

Qualcomm stock dropped sharply in pre-market trading after Nvidia CEO Jensen Huang introduced the RTX Spark superchip at Computex 2026 in Taipei. The new Arm-based processor, co-developed with Microsoft and planned for fall 2026 in systems from major OEMs, is positioned as a high-efficiency Windows on Arm platform and creates a direct competitive c…

Jun 1, 2026

Maya Rios

Stock Markets

Intel Shares Drop After Nvidia’s Surprise PC Chip Move at Computex

Intel shares plunged in pre-market trading as Nvidia revealed a new PC processor collaboration with Microsoft, prompting investors to reassess Intel’s premium valuation amid intensifying competition. The selloff came despite Intel’s own product reveal and follows recent analyst caution and signs of erosion in the company’s server CPU share and bala…

Jun 1, 2026

Marcus Reed

Stock Markets

Apotex Health Corp. Commences Roadshow for $1 Billion Initial Public Offering

Apotex Health Corp. has launched an initial public offering and started its investor roadshow after filing an amended preliminary prospectus with Canadian securities regulators. The company proposes to sell between 41.7 million and 50 million common shares priced at $20.00 to $24.00 each, targeting gross proceeds of roughly $1 billion. The transact…

Jun 1, 2026

Maya Rios

Press Releases

New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion

New Era Energy & Digital, Inc. announced participation in several major investor and industry conferences in June 2026, highlighting its leadership presence. The company also expects to be added to the Russell 3000 and Russell Microcap Indexes following the annual reconstitution, effective June 29, 2026. This inclusion signals increased visibility …

NUAI